XML 18 R7.htm IDEA: XBRL DOCUMENT v3.25.3
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY - USD ($)
$ in Thousands
Total
Common Stock
Treasury Stock
Additional Paid In Capital
Retained Deficit
Accumulated  Other Comp. Loss
Beginning balance (in shares) at Dec. 31, 2023   33,322,535        
Beginning balance at Dec. 31, 2023 $ 172,932 $ 333 $ (16,150) $ 265,217 $ (46,184) $ (30,284)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Share-based compensation expense (in shares)   3,438        
Share-based compensation expense 662   (2) 664    
Net income from continuing operations for the period 1,446       1,446  
Net income from discontinued operation for the period 1,493       1,493  
Other comprehensive (loss) income (994)         (994)
Ending balance (in shares) at Mar. 31, 2024   33,325,973        
Ending balance at Mar. 31, 2024 175,539 $ 333 (16,152) 265,881 (43,245) (31,278)
Beginning balance (in shares) at Dec. 31, 2023   33,322,535        
Beginning balance at Dec. 31, 2023 172,932 $ 333 (16,150) 265,217 (46,184) (30,284)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income from continuing operations for the period (736)          
Net income from discontinued operation for the period 11,588          
Other comprehensive (loss) income (7,440)          
Ending balance (in shares) at Sep. 30, 2024   33,494,483        
Ending balance at Sep. 30, 2024 179,265 $ 335 (16,209) 268,195 (35,332) (37,724)
Beginning balance (in shares) at Mar. 31, 2024   33,325,973        
Beginning balance at Mar. 31, 2024 175,539 $ 333 (16,152) 265,881 (43,245) (31,278)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Share-based compensation expense (in shares)   117,991        
Share-based compensation expense 1,332 $ 1 (18) 1,349    
Net income from continuing operations for the period (1,299)       (1,299)  
Net income from discontinued operation for the period (302)       (302)  
Other comprehensive (loss) income (5,663)         (5,663)
Ending balance (in shares) at Jun. 30, 2024   33,443,964        
Ending balance at Jun. 30, 2024 169,607 $ 334 (16,170) 267,230 (44,846) (36,941)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Share-based compensation expense (in shares)   50,519        
Share-based compensation expense 927 $ 1 (39) 965    
Net income from continuing operations for the period (883)       (883)  
Net income from discontinued operation for the period 10,397       10,397  
Other comprehensive (loss) income (783)         (783)
Ending balance (in shares) at Sep. 30, 2024   33,494,483        
Ending balance at Sep. 30, 2024 $ 179,265 $ 335 (16,209) 268,195 (35,332) (37,724)
Beginning balance (in shares) at Dec. 31, 2024 33,694,396 33,694,396        
Beginning balance at Dec. 31, 2024 $ 135,592 $ 337 (16,468) 269,117 (74,051) (43,343)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Share-based compensation expense (in shares)   (994)        
Share-based compensation expense 770     770    
Net income from continuing operations for the period (3,139)       (3,139)  
Net income from discontinued operation for the period (1,173)       (1,173)  
Other comprehensive (loss) income 4,606         4,606
Ending balance (in shares) at Mar. 31, 2025   33,693,402        
Ending balance at Mar. 31, 2025 $ 136,656 $ 337 (16,468) 269,887 (78,363) (38,737)
Beginning balance (in shares) at Dec. 31, 2024 33,694,396 33,694,396        
Beginning balance at Dec. 31, 2024 $ 135,592 $ 337 (16,468) 269,117 (74,051) (43,343)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income from continuing operations for the period (14,064)          
Net income from discontinued operation for the period (2,088)          
Other comprehensive (loss) income $ 14,399          
Ending balance (in shares) at Sep. 30, 2025 33,960,838 33,960,838        
Ending balance at Sep. 30, 2025 $ 136,527 $ 340 (16,570) 271,905 (90,204) (28,944)
Beginning balance (in shares) at Mar. 31, 2025   33,693,402        
Beginning balance at Mar. 31, 2025 136,656 $ 337 (16,468) 269,887 (78,363) (38,737)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Share-based compensation expense (in shares)   189,446        
Share-based compensation expense 972 $ 2 (11) 981    
Stock warrants issued in connection with debt - Note 12 0          
Net income from continuing operations for the period (4,106)       (4,106)  
Net income from discontinued operation for the period (655)       (655)  
Other comprehensive (loss) income 9,768         9,768
Ending balance (in shares) at Jun. 30, 2025   33,882,848        
Ending balance at Jun. 30, 2025 142,635 $ 339 (16,479) 270,868 (83,124) (28,969)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Share-based compensation expense (in shares)   77,990        
Share-based compensation expense 947 $ 1 (91) 1,037    
Net income from continuing operations for the period (6,820)       (6,820)  
Net income from discontinued operation for the period (260)       (260)  
Other comprehensive (loss) income $ 25         25
Ending balance (in shares) at Sep. 30, 2025 33,960,838 33,960,838        
Ending balance at Sep. 30, 2025 $ 136,527 $ 340 $ (16,570) $ 271,905 $ (90,204) $ (28,944)